Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: Results from the SWiTCH trial

Blood

Volumn 124, Issue 6, 2014, Pages 891-898

  Helton, Kathleen J ^a   Adams, Robert J ^b   Kesler, Karen L ^c   Lockhart, Alex ^c   Aygun, Banu ^d   Driscoll, Catherine ^e   Heeney, Matthew M ^f   Jackson, Sherron M ^b   Krishnamurti, Lakshmanan ^g   Miller, Scott T ^h   Sarnaik, Sharada A ⁱ   Schultz, William H ^j   Ware, Russell E ^j  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RHO INC   (United States)

^d Northwell Health   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

^j CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IRON OVERLOAD; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MIDDLE CEREBRAL ARTERY; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; STANDARD; TRANSCRANIAL DOPPLER; TRANSIENT ISCHEMIC ATTACK; VALIDATION PROCESS; VASCULAR DISEASE; YOUNG ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; BRAIN; BRAIN CIRCULATION; CLINICAL TRIAL; COMPLICATION; DOPPLER ECHOGRAPHY; FEMALE; FUNCTIONAL NEUROIMAGING; MALE; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PROGNOSIS; SECONDARY PREVENTION; STROKE; VASCULARIZATION;

HYDROXYUREA;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD FLOW VELOCITY; BLOOD TRANSFUSION; BRAIN; CEREBROVASCULAR CIRCULATION; CHILD; CHILD, PRESCHOOL; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; HYDROXYUREA; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; SECONDARY PREVENTION; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; YOUNG ADULT;

EID: 84905717623     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-12-545186     Document Type: Article

References (43)

1. Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med. 1978;65(3):461-471. (Pubitemid 8397664)
2. Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. Semin Hematol. 1991;28(3): 213-219.
3. Wang WC, Langston JW, Steen RG, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr. 1998;132(6):994-998. (Pubitemid 28280412)
4. Steen RG, Emudianughe T, Hankins GM, et al. Brain imaging findings in pediatric patients with sickle cell disease. Radiology. 2003;228(1): 216-225. (Pubitemid 36736094)
5. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W; Cooperative Study of Sickle Cell Disease. Mortality in children and adolescents with sickle cell disease. Pediatrics. 1989;84(3): 500-508. (Pubitemid 19216350)
6. Hariman LM, Griffith ER, Hurtig AL, Keehn MT. Functional outcomes of children with sickle-cell disease affected by stroke. Arch Phys Med Rehabil. 1991;72(7):498-502.
7. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore- Washington Cooperative Young Stroke Study. Neurology. 1998;51(1):169-176. (Pubitemid 28345379)
8. Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126(6):896-899.
9. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002;140(3): 348-354. (Pubitemid 34289713)
10. Wang WC, Kovnar EH, Tonkin IL, et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr. 1991;118(3): 377-382.
11. Castellino SM, Combs MR, Zimmerman SA, Issitt PD, Ware RE. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol. 1999;104(1):189-194. (Pubitemid 29037039)
12. Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol. 2007;14(6): 671-676. (Pubitemid 47494085)
13. Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000;96(1):76-79. (Pubitemid 30456453)
14. Ballas SK. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol. 2001;38(1 Suppl 1): 30-36. (Pubitemid 32110270)
15. Charache S, Terrin ML, Moore RD, et al; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332(20): 1317-1322.
16. Pavlakis SG, Prohovnik I, Piomelli S, DeVivo DC. Neurologic complications of sickle cell disease. Adv Pediatr. 1989;36:247-276.
17. Thornburg CD, Files BA, Luo Z, et al; BABY HUG Investigators. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012; 120(22):4304-4310, quiz 4448.
18. Wang WC, Ware RE, Miller ST, et al; BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778):1663-1672.
19. Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood. 2004; 103(6):2039-2045. (Pubitemid 38326218)
20. Ware RE, Zimmerman SA, Schultz WH. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood. 1999; 94(9):3022-3026. (Pubitemid 29512706)
21. Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr. 2004;145(3):346-352. (Pubitemid 39165683)
22. Ware RE, Schultz WH, Yovetich N, et al. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer. 2011;57(6):1011-1017.
23. Ware RE, Helms RW; SWiTCH Investigators. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood. 2012;119(17): 3925-3932.
24. Greenway A, Ware RE, Thornburg CD. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload. Am J Hematol. 2011;86(4):357-361.
25. Aygun B, Wruck LM, Schultz WH, et al; TCD With Transfusions Changing to Hydroxyurea (TWiTCH) Trial Investigators. Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities. Am J Hematol. 2012; 87(4):428-430.
26. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326(9):605-610.
27. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50(6): 1699-1708. (Pubitemid 28283238)
28. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992;120(3): 360-366.
29. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998; 91(1):288-294. (Pubitemid 28018756)
30. Powars DR, Conti PS, Wong WY, et al. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood. 1999;93(1): 71-79. (Pubitemid 29019390)
31. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996;17(5): 965-972. (Pubitemid 26149101)
32. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sicklecell anemia. N Engl J Med. 1972;287(17): 846-849.
33. Huttenlocher PR, Moohr JW, Johns L, Brown FD. Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics. 1984; 73(5):615-621. (Pubitemid 14143970)
34. Pavlakis SG, Bello J, Prohovnik I, et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol. 1988;23(2):125-130. (Pubitemid 18081449)
35. Gerald B, Sebes JI, Langston JW. Cerebral infarction secondary to sickle cell disease: arteriographic findings. AJR Am J Roentgenol. 1980;134(6):1209- 1212. (Pubitemid 10120292)
36. Russell MO, Goldberg HI, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood. 1984;63(1): 162-169. (Pubitemid 14224534)
37. Koshy M, Thomas C, Goodwin J. Vascular lesions in the central nervous system in sickle cell disease (neuropathology). J Assoc Acad Minor Phys. 1990;1(3):71-78.
38. Diggs LW. Intracranial hemorrhage in blacks as compared with whites. N Engl J Med. 1992; 327(8):568.
39. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med. 1980;302(18): 992-995. (Pubitemid 10125408)
40. Hulbert ML, McKinstry RC, Lacey JL, et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood. 2011; 117(3):772-779.
41. Brousse V, Hertz-Pannier L, Consigny Y, et al. Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease? Ann Hematol. 2009; 88(8):785-788.
42. Detterich JA, Sangkatumvong S, Kato R, et al. Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion. Transfusion. 2013; 53(5):1059-1068.
43. Brousse V, Gandhi S, de Montalembert M, et al. Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia. Br J Haematol. 2013;160(2): 259-261.